Cargando…

Durability of first antiretroviral treatment in HIV chronically infected patients: why change and what are the outcomes?

INTRODUCTION: First antiretroviral therapy (ART) is often switched to simpler, more potent or better tolerated regimens [1, 2]. Although discontinuation rates are frequently studied, the durability of regimens is rarely approached. MATERIALS AND METHODS: Retrospective study with the following object...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moniz, Patricia, Alçada, Filipa, Peres, Susana, Borges, Fernando, Baptista, Teresa, Claudia Miranda, Ana, Antunes, Isabel, Aldir, Isabel, Ventura, Fernando, Nina, Jaime, Mansinho, Kamal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P265
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225396/ https://www.ncbi.nlm.nih.gov/pubmed/25397541 http://dx.doi.org/10.7448/IAS.17.4.19797

Ejemplares similares

Improve screening of HCV infection by targeting high prevalence aged groups: analysis of a cohort of HCV and HIV co-infected patients
por: Brogueira, Pedro, et al.
Publicado: (2014)

Risk of liver decompensation assessed in HIV/HCV co-infected individuals with advanced liver fibrosis: a faster countdown experience
por: Pedro Alves, Joao, et al.
Publicado: (2014)

Evolution trends over three decades of HIV infection late diagnosis: the experience of a Portuguese cohort of 705 HIV-infected patients
por: Claudia Miranda, Ana, et al.
Publicado: (2014)

Clinical and laboratorial impact of antiretroviral therapy in a cohort of Portuguese patients chronically infected with HIV-2
por: Miranda, Ana, et al.
Publicado: (2014)

Analysis of hepatitis non-treatment causes in a cohort of HCV and HCV/HIV infected patients
por: Pereira, Karen, et al.
Publicado: (2014)

Évaluation de la fatigue au décours d’une pneumonie COVID-19 sévère : à propos de 273 cas
por: Marzouki, S., et al.
Publicado: (2022)

The impact of tenofovir disoproxil fumarate on kidney function: four-year data from the HIV-infected outpatient cohort
por: Monteiro, Nadine, et al.
Publicado: (2014)

Epidemiological surveillance and comparative analysis of patients with influenza like illness and other respiratory viruses
por: Nandi, T., et al.
Publicado: (2018)

PERFIL EPIDEMIOLÓGICO DE PNEUMONIA ASSOCIADA A VENTILAÇÃO MECÂNICA EM PACIENTES COVID-19 EM UM HOSPITAL DE CAMPANHA DE GOIÁS
por: Franco, Cristielly Guimarães, et al.
Publicado: (2022)

Hypovitaminosis D in HIV-infected patients in Lisbon: a link with antiretroviral treatment
por: Boura, Márcia, et al.
Publicado: (2014)

Acute Pyelonephritis with Bacteremia Caused by Enterococcus hirae: A Rare Infection in Humans
por: Pãosinho, Ana, et al.
Publicado: (2016)

A retrospective observational study of low-level viraemia and its immunological and virological significance: which outcome to expect
por: Silva, Joana, et al.
Publicado: (2014)

Tolerability is more important than simplicity for treatment durability
por: Trottier, Benoit, et al.
Publicado: (2014)

Causes of virological failure in a population of 1895 HIV-infected patients: the experience of an infectious diseases service in Lisbon, Portugal
por: Moneti, V, et al.
Publicado: (2012)

Patient preferences for characteristics of antiretroviral therapies: results from five European countries
por: Gazzard, Brian, et al.
Publicado: (2014)

Nuke-sparing regimens as a main simplification strategy and high level of toxicity resolution after antiretroviral switch: the SWITCHART Study
por: Carrero-Gras, Ana, et al.
Publicado: (2014)

Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting
por: Gianotti, Nicola, et al.
Publicado: (2014)

Who gets single tablet regimens (STR), and why?
por: Tarrier, Laura, et al.
Publicado: (2014)

Management of HIV-2 resistance to antiretroviral therapy in a HIV-1/HIV-2/HBV co-infected patient
por: Cardoso, Margarida, et al.
Publicado: (2021)

Factors involved in treatment durability and immunological recovery in a cohort of HIV-positive patients receiving atazanavir-based regimens
por: Giacomelli, Andrea, et al.
Publicado: (2014)

Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens
por: Philippe Küpper-Tetzel, Claus, et al.
Publicado: (2014)

Antiretroviral therapy (ART) management of Low-Level Viremia in Taiwan (ALLEVIATE)
por: Cheng, Chien-Yu, et al.
Publicado: (2014)

Acceptability and confidence in antiretroviral generics of physicians and HIV-infected patients in France
por: Allavena, Clotilde, et al.
Publicado: (2014)

Hidden costs of HIV treatment in Spain: inefficiency of the antiretroviral drug packaging
por: Llibre-Codina, Josep M, et al.
Publicado: (2014)

Effectiveness and durability of darunavir/ritonavir (DRV/r) in DRV/r-experienced HIV-1-infected patients in routine clinical practice
por: Antinori, Andrea, et al.
Publicado: (2014)

New dolutegravir resistance pattern identified in a patient failing antiretroviral therapy
por: Carganico, Andreas, et al.
Publicado: (2014)

Patients’ willingness to take separate component antiretroviral therapy regimens for HIV in the Netherlands
por: Engelhard, Esther, et al.
Publicado: (2014)

Treatment modification in HIV-Infected individuals starting antiretroviral therapy between 2011 and 2014
por: Rappold, Michaela, et al.
Publicado: (2014)

Time to virologic failure for patients taking their first antiretroviral regimen and the subsequent resistance profiles
por: Crouzat, Frederic, et al.
Publicado: (2014)

Transmitted antiretroviral drug resistance in treatment naïve HIV-infected persons in London in 2011 to 2013
por: McFaul, Katie, et al.
Publicado: (2014)

Transmitted antiretroviral drug resistance mutations in newly diagnosed HIV-1 positive patients in Turkey
por: Sayan, Murat, et al.
Publicado: (2014)

Lipohypertrophy and metabolic disorders in HIV patients on antiretroviral therapy: a systematic multidisciplinary clinical approach
por: Sculier, Delphine, et al.
Publicado: (2014)

Efficacy, safety, and lack of interactions with the use of raltegravir in HIV-infected patients undergoing antineoplastic chemotherapy
por: Bañón, Sara, et al.
Publicado: (2014)

Lipid changes in HIV-patients switching to the coformulated single tablet FTC/RPV/TDF (Eviplera(®)). Efficacy and safety analysis. GeSida Study 8114
por: Pérez-Hernández, Isabel A, et al.
Publicado: (2014)

Insights into antiretroviral treatment changes in previously naïve patients: results of a Portuguese cohort
por: Silva, C, et al.
Publicado: (2010)

Attitudes of serodiscordant couples towards antiretroviral-based HIV prevention strategies in Kenya: a qualitative study
por: Fowler, Nikola, et al.
Publicado: (2014)

The suspected unexpected and serious adverse events of antiretroviral drugs used as HIV prophylaxis in HIV uninfected persons
por: Pietraszkiewicz, Ewa, et al.
Publicado: (2014)

Potential drug–drug interactions in HIV-perinatally infected adolescents on antiretroviral therapy in Buenos Aires, Argentina
por: Cordova, Ezequiel, et al.
Publicado: (2014)

The CD4:CD8 ratio is associated with IMT progression in HIV-infected patients on antiretroviral treatment
por: Bernal, Enrique, et al.
Publicado: (2014)

Quality of life of people living with HIV, preliminary results from IANUA (Investigation on Antiretroviral Therapy) study
por: Venturini, Alberto, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2605hpdhp0lh0coidv0s8i3gdc